Khosla Impact, established in 2013, is an impact investment firm based in Menlo Park, California. It focuses on assisting high-impact entrepreneurs who develop products and services for the three billion people at the bottom of the world's economic pyramid. The firm invests in for-profit enterprises serving low-income individuals and small businesses in emerging markets, with a primary focus on South Asia. Khosla Impact encourages experimentation and supports entrepreneurs passionate about solving socio-economic challenges through technology and innovative business models.
Industrial Next specializes in the development of advanced technologies aimed at automating production processes. The company focuses on creating AI-powered workstations that utilize proprietary learning, vision, and control software to streamline manual assembly tasks. By integrating hardware and software solutions, Industrial Next enables manufacturing companies to improve efficiency and precision in their assembly lines, thereby facilitating flexible and intelligent production automation.
Exaforce
Series A in 2025
Exaforce specializes in cloud security, offering a platform that empowers high-growth startups' security teams. This platform provides real-time visibility into security posture, risk assessment, and incident response, enabling proactive threat detection and remediation, thereby strengthening customers' overall cloud security.
Loti
Series A in 2025
Loti is a pioneering identity management solution focused on protecting individuals' identities online. The platform employs advanced facial recognition technology and automated processes to detect unauthorized uses of an individual's likeness, including deep fakes and other privacy infringements. By scanning the internet for instances of identity misappropriation, Loti empowers users to maintain control over their digital identity, ensuring their images are not misused without consent. The system facilitates the monitoring, reporting, and issuing of takedown notices, allowing for prompt action against unauthorized content across various online platforms. Committed to privacy, security, and ethical practices, Loti prioritizes the rights and consent of individuals while implementing robust technology to combat identity misuse.
Roam
Series A in 2025
Roam is the platform for affordable home ownership. Roam helps homebuyers purchase their next home with a low-interest rate mortgage included.
Spiritus
Series A in 2025
Spiritus is a climate technology company focused on advancing direct-air-capture (DAC) solutions to combat climate change. It has developed a unique system that integrates the Spiritus Sorbent and the Spiritus Carbon Orchard, designed to be both scalable and modular, which allows for cost-effective carbon removal and sequestration. The company aims to provide an accessible and practical approach to carbon removal, enabling clients to manage their carbon footprint effectively and contribute to environmental sustainability. By achieving efficient sorption and desorption rates at a lower cost compared to existing technologies, Spiritus positions itself as a leader in the DAC sector.
Atomicwork
Series A in 2025
Atomicwork is a service management software provider that focuses on enhancing the employee experience through seamless integration with everyday communication tools like Microsoft Teams, Slack, and email. Founded in 2022 and based in San Francisco, California, the company offers a platform that allows employees to address IT issues without navigating cumbersome portals. Atomicwork's technology facilitates efficient interactions by providing an employee service concierge to quickly find answers, submit requests, and obtain approvals. Its solutions aim to connect employees with operational teams and streamline workflows, ultimately bridging gaps across various workplace tools and processes.
Basis
Series A in 2024
Basis develops AI agents that assist accountants by automating accounting workflows. The agents integrate with existing systems and adapt to the needs of each engagement. The company serves industries such as finance and accounting.
Physical Intelligence
Series A in 2024
Physical Intelligence is a technology company specializing in integrating artificial intelligence with robotics and physical devices. It develops foundational models and learning algorithms to enable robots and other physical devices to perform a wide range of tasks across various industries.
RedoxBlox
Series A in 2024
RedoxBlox specializes in thermochemical energy storage technology aimed at decarbonizing high-temperature industrial thermal processing and enhancing natural gas power production. By providing a cost-effective alternative to fossil fuels, the company enables continuous energy discharge at high temperatures, significantly reducing carbon and nitrogen oxide emissions. Its system is designed to integrate seamlessly with existing infrastructure, improving grid resilience while supporting industrial processors and power plant operators. RedoxBlox's technology facilitates the electrification and storage of energy, allowing industries to harness renewable energy sources through large-scale, long-duration energy storage solutions.
Even
Series A in 2024
Even is a health tech company that collaborates with leading hospitals to provide comprehensive healthcare services through a subscription model. Its offerings include unlimited diagnostics, consultations, and hospitalization coverage valued at up to 50 lakh. The company simplifies the reimbursement process by directly transferring funds to partner hospitals, ensuring a seamless experience for members. By charging a recurring monthly fee, Even aims to address critical long-term health needs for individuals, making healthcare more accessible and manageable.
Genie AI
Series A in 2024
Genie AI Limited is a company based in London, United Kingdom, that specializes in artificial intelligence solutions for the legal sector. It has developed a platform called SuperDrafter, which utilizes machine learning to assist lawyers in drafting contracts more efficiently by leveraging the collective knowledge of their firm. Additionally, Genie AI offers a feature known as Anonymiser that automatically redacts sensitive information from contracts. The company also organizes educational events and training sessions focused on smart contracts and the application of artificial intelligence in legal practices. Founded in 2017, Genie AI aims to enhance the contract drafting process, allowing lawyers to manage client risks and negotiate effectively within tight deadlines.
Rogo
Series A in 2024
Rogo is the secure, state-of-the-art Generative AI platform purpose-built for elite financial institutions. Trusted by thousands of investment bankers, asset managers, and private equity professionals, Rogo streamlines workflows, rapidly unlocks strategic insights, and saves valuable time—all within the industry's most rigorous security standards. Empower your team to analyze, automate, and innovate with confidence
Enzymit
Series A in 2024
Enzymit is focused on transforming global manufacturing by advancing cell-free bio-production technology, which aims to reduce reliance on scarce resources and enhance sustainability. The company develops novel enzymes using artificial intelligence and deep learning algorithms, enabling the creation of innovative molecular machines that can convert abundant feedstocks into valuable products across various sectors, including pharmaceuticals, cosmetics, food, and materials. By employing small, modular bio-reactors, Enzymit enhances efficiency, reduces costs, and minimizes environmental impact compared to traditional whole-cell bio-production methods. This approach not only fosters resource independence but also allows for greater flexibility in product customization, positioning Enzymit as a competitive alternative to conventional chemical manufacturing.
Distyl
Series A in 2024
Distyl AI specializes in helping organizations enhance their readiness for artificial intelligence by developing customized AI solutions that align with their specific data, workflows, and workforce needs. The company offers a generative AI solutions platform that supports major institutions in adopting foundational models and preparing for AI integration. By collaborating with leading organizations globally, Distyl AI aims to create reliable and seamlessly integrated AI-driven services, enabling enterprises to thrive in an increasingly AI-assisted economy.
Synex Medical
Series A in 2024
Synex Medical specializes in non-invasive blood testing technology, focusing on the development of a portable device that enables users to monitor metabolite concentrations without penetrating the skin. Utilizing a miniaturized magnetic resonance system, the company can accurately detect critical blood metabolites such as glucose, lactate, and ketones. This innovative approach employs only magnets and radio waves, ensuring there are no adverse health effects associated with its use. By providing precise information about metabolic health, Synex Medical aims to empower individuals to take proactive steps in managing their health and well-being.
Noetik
Series A in 2024
Noetik is an AI-native biotechnology company focused on the discovery and development of cancer immunotherapies. Utilizing advanced machine learning techniques, Noetik's platform identifies new therapeutic targets and designs innovative treatments. By leveraging self-supervised learning and integrating human multimodal data, the company aims to enhance the effectiveness and personalization of cancer therapies, thereby improving patient outcomes in oncology.
DevRev
Series A in 2024
DevRev is a business software startup that aims to enhance the relationship between developers and customers by integrating development with customer relationship management (CRM). The company focuses on breaking down barriers between developers and end-users, facilitating direct communication and collaboration to foster customer-centric product development. DevRev employs a unique approach that combines collaboration, artificial intelligence, and analytics, allowing software-as-a-service (SaaS) companies to improve product velocity and minimize customer churn. Its platform is designed to streamline product development and customer service, offering a developer-centric CRM that leverages data and machine intelligence. DevRev serves thousands of businesses seeking low-latency analytics and customizable large language models to thrive in the evolving landscape of generative AI.
Planted Solar
Series A in 2024
Planted Solar is a developer focused on transforming the solar power landscape through an innovative platform that enhances the design and installation of solar power plants. By leveraging development software and construction robots, the company creates high-density, all-terrain power plants on land that was previously deemed unsuitable for solar energy production. This approach allows Planted Solar to generate twice the energy per acre and complete projects three times faster than traditional methods. The company aims to empower businesses and corporations to manage their energy consumption more efficiently, contributing to a cleaner and more sustainable energy future. Backed by prominent investors such as Breakthrough Energy Ventures and Khosla Ventures, Planted Solar is dedicated to accelerating the deployment of solar energy solutions globally.
WindBorne Systems
Venture Round in 2024
WindBorne Systems Inc., founded in 2019 and based in Stanford, California, specializes in developing and operating a network of smart weather balloons for atmospheric data collection. The company utilizes high-altitude balloons equipped with advanced sensors to gather precise measurements from various layers of the atmosphere. This data is crucial for weather forecasting, climate research, and environmental monitoring, allowing for more accurate predictions and better preparedness for severe weather events. WindBorne Systems distributes its information to both government and private weather services, contributing to efforts aimed at mitigating the impacts of climate change and improving overall understanding of climatic conditions, even in previously inaccessible regions.
Honey Homes
Series A in 2024
Honey Homes is a home maintenance firm that specializes in offering a range of services to assist homeowners with various maintenance tasks. The company provides handyman services, electrical work, plumbing, as well as interior and exterior maintenance. Through its user-friendly website and applications, Honey Homes enables homeowners to easily access these services, promoting proactive home upkeep and saving time on small jobs around the house.
Zeck
Series A in 2024
Zeck is a developer of a board management platform that enhances board engagement and automates governance processes. The platform offers customizable frameworks for organizing meetings and includes tools for auto-generating and approving meeting minutes, facilitating secure voting, and signing documents. By providing these features, Zeck aims to streamline board governance and improve compliance for businesses. In addition to its core functionalities, the application incorporates communication features specifically designed for meetings, further supporting effective collaboration among board members.
Cognition
Series A in 2024
Cognition AI is an applied AI lab focused on building end-to-end software agents that act as collaborative AI teammates. Their aim is to support engineering teams in being more efficient and innovative in their projects.
Rubedo Life Sciences
Series A in 2024
Rubedo Life Sciences, Inc. is a biopharmaceutical company based in Sunnyvale, California, focused on developing therapies that target senescent cells responsible for various age-related diseases. Established in 2018, the company utilizes its proprietary ALEMBIC drug discovery platform to create a pipeline of innovative therapeutic candidates. These candidates include novel small molecules designed to selectively address senescent cells, which contribute to the progression of several chronic conditions, including pulmonary, dermatological, oncological, neurodegenerative, and fibrotic diseases. Rubedo's leadership team comprises experienced professionals from the fields of chemistry, technology, and life sciences, bringing a wealth of knowledge in drug development and commercialization.
Loft Labs
Series A in 2024
Loft Labs, established in 2019 and headquartered in Berkeley, California, specializes in providing secure, self-service access to Kubernetes for organizations. Their flagship product, Loft, is a unified Kubernetes platform that combines several open-source projects, including DevSpace, vcluster, jsPolicy, and kiosk. Loft enables companies to scale access to Kubernetes from a small to a large number of engineers, promoting secure and efficient cloud-native engineering practices.
Nabla Bio
Series A in 2024
Nabla Bio operates an autoreverse platform that facilitates the rapid discovery of novel protein variants with unique properties. By leveraging insights gained from billions of natural proteins, the company engineers these enhanced proteins for both medical and industrial applications. Through extensive experimentation, Nabla Bio develops new medicines and improves nutritional products, allowing clients to conduct complex measurements of protein function and implement innovative solutions in various fields.
Symbolica AI
Series A in 2024
Symbolica AI is a research-driven company that develops a unique business model platform. This platform leverages geometric and topological principles in machine learning to train models using formal computational logic, rather than traditional statistical methods. The result is enhanced decision-making capabilities for clients, fostering business growth.
Metaplane
Series A in 2024
Metaplane provides data observability solutions that help organizations build trust in their data. Its platform is utilized by data teams from various notable companies, including Bose and Sotheby's, to streamline engineering processes and proactively address data issues before they escalate. By automatically monitoring modern data infrastructures—from data warehouses to business intelligence dashboards—the platform identifies normal operational behaviors and alerts users when anomalies occur. This capability allows teams to understand data disruptions and implement corrective measures efficiently. Founded by alumni from MIT and HubSpot, Metaplane is supported by prominent investors, including Y Combinator and various tech industry founders. The company's focus is on enabling businesses to act on data insights rather than sifting through information, ultimately reducing customer churn and enhancing upsell opportunities.
Limbic
Series A in 2024
Limbic is a London-based company that specializes in mental healthcare technology. Founded in 2017, it develops a software development kit (SDK) that leverages machine learning to analyze heart rate data collected from wearable devices like the Apple Watch, allowing for the assessment of users' emotional states. Limbic also offers psychological therapies for adults, focusing on improving mental health through innovative solutions. Its platform supports healthcare professionals by providing tools for stress detection and facilitating clinical assessments, thereby enhancing the efficacy of psychological therapy. By combining AI technology with wearable devices, Limbic aims to address the growing challenges in mental health care and improve patient outcomes.
Aktiia
Series A in 2024
Aktiia focuses on continuous and accurate blood pressure monitoring to address the global challenge of hypertension, which affects over 1.4 billion people and contributes to more than 18 million deaths annually. Founded on two decades of research, Aktiia's innovative technology combines optical sensors with clinically validated software algorithms to provide personalized, medical-grade blood pressure and heart rate data. This continuous monitoring enables individuals, researchers, and clinicians to gain deeper insights into hypertension, fostering more effective and personalized patient care. By improving accessibility and accuracy in blood pressure management, Aktiia aims to change the approach to this critical health issue, ultimately enhancing the understanding and treatment of high blood pressure.
Daedalus
Series A in 2024
Daedalus is a contract manufacturing company that specializes in precision parts for the CNC industry. It leverages advanced robotics and artificial intelligence to create reconfigurable production capacity, allowing for instant retooling to accommodate various manufacturing needs. The company offers a software system that enhances manufacturing efficiency and ensures high reliability and transparency throughout the production process. Daedalus is equipped to handle a wide range of production scales, from prototypes to large-scale manufacturing, thereby supporting diverse customer requirements with agility in both process and part complexity.
Recraft
Series A in 2024
Recraft is a creative AI tool.
Overmoon
Series A in 2024
Overmoon is a provider of vacation house rental services focused on family-oriented accommodations. The company offers a curated selection of rentals that combine the comforts of home with the reliability of a hotel experience. By owning and managing these properties, Overmoon aims to create a hassle-free environment for customers, allowing families and friends to enjoy their vacation stays without the typical stresses associated with travel. This approach seeks to transform the vacation rental industry by prioritizing the needs and preferences of families.
Moonwalk Biosciences
Series A in 2024
Moonwalk Biosciences is a genomic medicine startup focused on developing precision epigenetic therapeutics. The company is creating a profiling and engineering technology platform that leverages advanced artificial intelligence to deliver an in-depth understanding of the epigenome in both health and disease. This innovative approach allows healthcare providers to explore new avenues for therapy discovery and facilitates the reprogramming of cells to restore their healthy state. By integrating AI-driven insights, Moonwalk Biosciences aims to transform the landscape of therapeutic development and improve patient outcomes.
rabbit
Series A in 2023
rabbit inc. is a technology company developing consumer electronics driven by novel, simple, and intuitive interactive paradigms. rabbit is the creator of the Large Action Model (LAM), a new type of foundation model for human actions on computer applications, and rabbit OS, a personalized operating system through a natural language interface. rabbit's first product, rabbit r1, is an affordable companion device designed in collaboration with Teenage Engineering.
Encellin
Series A in 2023
Encellin, Inc. is a biotechnology company based in San Francisco, California, founded in 2015. It specializes in developing innovative cell-based therapeutics, particularly focusing on a novel thin-film cell encapsulation device. This device utilizes advanced thin-film cell delivery technology, which encapsulates and replaces cells, allowing the enclosed cells to operate as smart molecular factories. Encellin's primary mission is to provide effective treatments for patients with chronic diseases, with an initial emphasis on Type 1 diabetes. The company is committed to advancing next-generation therapies through the expertise of its dedicated team.
Sarvam AI
Series A in 2023
Sarvam AI focuses on advancing artificial intelligence research to enhance the performance, reliability, and affordability of generative AI application development in India. The company develops sophisticated large language models tailored to the country's diverse linguistic environment, providing a user-friendly platform for creating and assessing generative AI applications. Sarvam AI emphasizes open-source collaboration, allowing businesses to leverage modern AI technology to gain a competitive advantage in their respective markets.
Kognitos
Series A in 2023
Kognitos is an AI platform that focuses on automating business processes to enhance operational efficiency. Founded in 2021 and headquartered in San Jose, California, Kognitos provides software that simplifies daily business operations. Its platform allows users to manage complex end-to-end processes through straightforward English commands, making automation accessible and user-friendly. This approach enables businesses to scale effectively with minimal initial investment, streamlining workflows and increasing productivity.
Aleph
Series A in 2023
Aleph operates a financial planning and analysis platform designed to enhance the capabilities of traditional spreadsheets such as Excel and Google Sheets. By integrating data from accounting systems and various operational sources, Aleph provides specialized financial tools that are always current. This allows clients to create sophisticated financial models and use cases, ultimately facilitating informed investment decisions. Aleph aims to support finance departments by merging the familiarity of spreadsheets with advanced financial insights, making it a valuable resource for financial professionals.
LuzIA
Series A in 2023
Luzia has developed an AI platform that specializes in transcribing audio messages on WhatsApp. The platform features a user-friendly chatbot accessible through WhatsApp, which can respond to inquiries across diverse topics, generate text, translate languages, and create creative content. This technology empowers users to efficiently perform a variety of tasks, enhancing communication and information access within the WhatsApp environment.
Mojo Vision
Series A in 2023
Mojo Vision Inc. is a company based in Saratoga, California, established in 2015, that specializes in augmented reality technology. The firm is focused on developing high-performance micro-LED displays for various applications, including consumer, enterprise, and government sectors. It has created the world's smallest and densest dynamic display integrated into a smart contact lens, designed to provide users with timely information without disrupting their focus. This innovative product allows for hands-free connectivity and access to relevant information, thereby minimizing reliance on traditional mobile devices. Additionally, Mojo Vision has formed a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products further, leveraging its advanced micro-LED technology and manufacturing processes to disrupt the display industry.
CellFE
Series A in 2023
CellFE Inc. is a San Carlos, California-based company that specializes in the development of a microfluidics-based device designed to deliver gene-editing molecules into human cells. Founded in 2017, CellFE's innovative platform employs rapid cell compressions to enhance the uptake of therapeutic molecules from the surrounding fluid, facilitating the development and manufacturing of advanced cell therapies. This technology aims to address previously inaccessible cell therapies, enabling medical researchers to transport difficult-to-deliver molecules into cells for the treatment of various disorders, ultimately improving patient outcomes.
Bold
Series A in 2023
Bold is an at-home digital fitness program designed to help older adults live their strongest, happiest, and healthiest lives. As a member, you’ll enjoy instant access to expert trainers, scientific assessments, and personalized workout plans to help you improve your strength, flexibility, and balance — so you can chase the life you want, at any age.
Ello
Series A in 2023
Ello focuses on transforming children's reading experiences by integrating artificial intelligence with traditional books, thereby providing personalized learning through evidence-based reading instruction. The company aims to assist children who encounter difficulties while reading and employs behavioral psychology techniques to encourage continued engagement with the material. By fostering a personal connection with real books, Ello seeks to nurture children's natural curiosity and cultivate a lifelong love for learning. Through its innovative approach, Ello positions itself as a leader in the educational technology space, dedicated to enhancing literacy and making reading a more accessible and enjoyable journey for young learners.
Spiritus
Series A in 2023
Spiritus is a climate technology company focused on advancing direct-air-capture (DAC) solutions to combat climate change. It has developed a unique system that integrates the Spiritus Sorbent and the Spiritus Carbon Orchard, designed to be both scalable and modular, which allows for cost-effective carbon removal and sequestration. The company aims to provide an accessible and practical approach to carbon removal, enabling clients to manage their carbon footprint effectively and contribute to environmental sustainability. By achieving efficient sorption and desorption rates at a lower cost compared to existing technologies, Spiritus positions itself as a leader in the DAC sector.
Caelux
Series A in 2023
Caelux is a renewable energy company based in Pasadena, California, that specializes in developing perovskite-on-glass technology for the terrestrial solar industry. Founded in 2014, the company focuses on creating innovative solar power products that enhance power production and efficiency while minimizing the use of semiconducting materials. This approach not only improves the performance of solar devices but also reduces production costs. Caelux's technology is designed to integrate seamlessly into existing photovoltaic module manufacturing processes, enabling users to lower installed costs while achieving better energy output.
Collaborative Robotics
Series A in 2023
Collaborative Robotics is a team of innovators and builders redefining the future of human-robot interaction. A future in which robots are trustworthy extensions of the environment. They operate, adapt, and react in response.
SiPhox Health
Series A in 2023
SiPhox Health, based in Cambridge, Massachusetts, specializes in designing and manufacturing innovative diagnostic solutions. The company develops next-generation diagnostics infrastructure, including at-home test kits and central lab systems. Their flagship product is a disposable biosensor cartridge that assesses 17 blood biomarkers, providing insights into inflammation, hormonal health, metabolic fitness, and cardiovascular health. SiPhox Health's platform merges biochemistry, photonic chip technology, integrated photonics, electronics, and microfluidics to enable sensitive readouts of immunoassays and nucleic acid tests, facilitating point-of-need and at-home diagnostics.
Honey Homes
Series A in 2023
Honey Homes is a home maintenance firm that specializes in offering a range of services to assist homeowners with various maintenance tasks. The company provides handyman services, electrical work, plumbing, as well as interior and exterior maintenance. Through its user-friendly website and applications, Honey Homes enables homeowners to easily access these services, promoting proactive home upkeep and saving time on small jobs around the house.
Credit Genie
Series A in 2023
Credit Genie is a fintech company that provides financial tools and debt relief services. It helps Americans take control of their finances, by offering no-fee-or-interest cash advances between paydays, tools to get out of debt, and insights into their spending habits.
Korbit Technologies
Series A in 2023
Korbit Technologies, founded in 2018 and headquartered in Montreal, Canada, is focused on revolutionizing education through its AI-powered tutor, Korbi. This intelligent platform offers personalized learning experiences by adapting to each student's unique profile, providing interactive exercises, quizzes, visual diagrams, and real-time feedback. Korbi aims to enhance learning outcomes and motivation for students by delivering targeted pedagogical support in areas such as data science and artificial intelligence. The company also offers a free machine learning course and serves a diverse clientele, including students, educators, and corporations. With nearly 20,000 learners benefiting from its training programs, Korbit has gained recognition as one of the top AI startups globally, supported by partnerships with institutions like Mila, and has received media coverage from prominent outlets such as the New York Times and Forbes.
Gather Health
Series A in 2023
Gather Health is an international healthcare technology company dedicated to empowering patients with chronic diseases to enhance their health. The company specializes in mobile and cloud-based healthcare applications that utilize the latest medical and behavioral change research to motivate and educate patients. By connecting physicians, patients, their families, and patient communities, Gather Health aims to provide continuous and holistic care, ultimately improving health outcomes. The rise in chronic diseases, such as obesity and diabetes, has created a demand for better care, which Gather Health addresses by equipping patients and healthcare providers with effective tools for managing these conditions. Their flagship product, the Gather Health Diabetes platform, has been successfully implemented in cities including Mumbai, Ahmedabad, Hyderabad, Chennai, and Bangalore, showing positive health outcomes for patients and increased efficiency for healthcare providers. Headquartered in Hong Kong, with offices in Beijing, New York, and India, Gather Health's team comprises clinicians, health experts, interaction designers, and engineers experienced in global healthcare.
Tachyon
Series A in 2023
Tachyon Therapeutics is a biotechnology company focused on developing innovative therapeutics for cancer treatment. The firm specializes in creating selective compounds that target significant drug targets within cancer biology, employing advanced methodologies in molecular cancer biology, epigenetics, and cancer stem cell biology. Currently, Tachyon is conducting Phase 1 clinical trials to evaluate the safety, pharmacokinetics, and anti-tumor effectiveness of its lead compound, TACH101, in patients with advanced cancer. The company's research and development efforts aim to unlock new pathways for treating challenging cancer types, ensuring that its programs are advanced in a timely and scientifically rigorous manner.
Quell
Series A in 2023
Quell, Inc. is a San Francisco-based company founded in 2020 that creates an immersive fitness experience combining gaming with physical workouts. The company offers a unique fitness game where players engage in combat within a fantasy world, utilizing low-cost wearable smart resistance bands to enhance their workouts at home. Quell positions itself as a blend of traditional fitness platforms and gaming, providing an innovative approach to achieving fitness goals. To maintain ongoing engagement, Quell charges a monthly subscription fee for access to fresh content and experiences.
Regie.ai
Series A in 2023
Regie.ai is a developer of an AI-powered platform that focuses on enhancing sales engagement and automating outbound prospecting. Its product, RegieOne, combines various functionalities such as sales engagement, parallel dialing, data enrichment, and intent analysis, allowing operations teams to manage their processes efficiently from a centralized interface. Additionally, Regie.ai's platform facilitates the creation, testing, and analysis of personalized sales campaigns, thereby improving engagement and optimizing the performance of frontline sales teams. Through its innovative approach, Regie.ai aims to streamline sales workflows and drive better outcomes for businesses.
LuxWall
Venture Round in 2023
LuxWall is a building materials company that pioneers the design and manufacture of vacuum-insulated glass. LuxWall produces glass that acts as transparent insulation, providing thermal insulation values comparable to fiberglass wall insulation. With widespread adoption, LuxWall's patented technology has the potential to reduce global carbon emissions by more than 0.5 gigatonnes per year. The company was founded in 2020 and is headquartered in Ypsilanti, Michigan, United States.
Atmos
Series A in 2022
Atmos is a company that has developed a comprehensive home-building platform designed to assist customers in creating and designing customized houses. Established in 2018 by Trent Hedge, Nicholas Donahue, Matthew Rastovac, and Austin Kahn, Atmos aims to streamline the home-building process by offering a managed marketplace that connects home buyers with various design options and personalized packages. The platform provides a diverse selection of designs and interiors, along with integrated financing and construction processes, enabling customers to build homes tailored to their specific preferences and financial situations.
SURGE Therapeutics
Series A in 2022
SURGE Therapeutics is dedicated to enhancing cancer patient survival through innovative approaches in immunotherapy. The company has developed a proprietary injectable biodegradable hydrogel designed for the prolonged and localized release of cancer immunotherapy following surgical tumor resection. By targeting the administration of treatment to specific areas at the optimal time, SURGE Therapeutics aims to improve the effectiveness of immunotherapy, allowing for both intravenous and intratumoral injections. This technology seeks to disrupt traditional cancer treatment paradigms and provide better outcomes for patients.
Good Health Company (Clinic) (GHC)
Series A in 2022
Mars is a men's wellness brand. The company provides hair, beard, skin, performance and wellness products. Mars was established on January 31, 2021 by Samarth Sindhi in Hyderabad, Andhra Pradesh.
Ochre Bio
Series A in 2022
Ochre Bio Ltd is a biotechnology company focused on developing genomic medicines to improve outcomes for liver transplant patients. Established in 2019 and headquartered in Headington, United Kingdom, the company specializes in rejuvenating donor livers before transplantation, ensuring that more patients in need of a new liver receive one. Utilizing advanced genomic techniques, Ochre Bio identifies and targets over-active genes that contribute to liver diseases. The company tests its novel RNA-based therapies on discarded donor livers kept alive outside the body, allowing for direct evaluation of treatment efficacy. With roots in over 15 years of liver genomics research, Ochre Bio aims to address liver-related conditions and enhance the availability of healthy livers for transplantation.
Arpeggio Bio
Series A in 2022
Arpeggio Bio, established in 2017 and headquartered in Boulder, Colorado, specializes in developing innovative software that captures snapshots of cellular RNA activity. By combining biological assays with advanced machine learning algorithms, the company enables pharmaceutical and biotechnology firms to understand a drug's mechanism of action at low sequencing depths. Arpeggio Bio's technology reveals intricate biological networks, facilitating more informed therapeutic development.
Genecis
Series A in 2022
Genecis is an early-stage organic waste processing startup that uses biotechnology to convert waste into biodegradable plastics and other high-value materials. It converts organic waste into PHA (Polyhydroxyalkanoate), a biodegradable, compostable, and non-toxic polymer that can be tuned to replace a wide variety of traditional plastics. PHA can be used for single-use plastics, clothing and textiles, automotive interiors, medical tools and products, and food contact applications.
Li Industries
Series A in 2022
Li Industries is a start-up dedicated to advancing lithium-ion battery recycling technologies. The company focuses on reclaiming materials from end-of-life batteries used in electric vehicles, consumer electronics, and various energy storage systems. By utilizing direct recycling technology, Li Industries specializes in recovering valuable metals such as lithium, cobalt, and nickel, which are essential for battery production. Their innovative electrochemical flow system allows for non-destructive lithiation and optimizes the post-treatment of recovered materials, enhancing the efficiency of the recycling process. Through its efforts, Li Industries aims to minimize environmental waste, lower emissions, and reduce the costs associated with lithium-ion battery manufacturing, thereby promoting a more sustainable supply chain for battery materials.
Lead
Funding Round in 2022
Lead Bank is a commercial bank based in Garden City, Missouri, established in 1928. It provides a comprehensive range of banking and financial services aimed at promoting economic growth for businesses. The bank offers business accounts, cash management, credit card services, and business loans, along with online and mobile banking options. Additionally, Lead Bank specializes in transaction and financial advisory services, including interim executive placements, financial and strategic planning, mergers and acquisitions advisory, private equity placements, capital sourcing, and business valuations. Through its division, Lead Business Advisors, the bank also delivers advisory services that encompass bookkeeping and business brokerage.
Neon
Series A in 2022
Neon is a cloud-native, fully managed Postgres as a service. By separating storage from computing, Neon offers autoscaling, branching, and bottomless storage to give developers a simple, reliable, and powerful experience. Neon aims to provide a highly performant and cost-effective database infrastructure by leveraging cloud-native technologies and innovative architectural features.
Traba
Series A in 2022
Traba operates a human resource marketplace designed to connect industrial businesses with reliable workers for open shifts. The platform facilitates the matching of workers with opportunities in warehouses, distribution centers, and event venues, allowing both parties to maximize productivity and earning potential. By streamlining the process of filling shifts, Traba enables businesses to maintain operational efficiency while providing workers with accessible employment opportunities.
Faeth Therapeutics
Series A in 2022
Faeth Therapeutics is a healthcare company dedicated to enhancing cancer treatment through a deep understanding of the relationship between dietary nutrients and tumor growth. By aligning specific diets with tumor genotypes and treatment regimens, Faeth aims to limit the energy and resources that tumors need to proliferate, thereby improving patient outcomes in cancer therapy. Founded by leading researchers and clinicians, the company seeks to translate significant discoveries from cancer research laboratories into effective clinical practices, focusing on evidence-based approaches to optimize treatment strategies for cancer patients.
CHARM Therapeutics
Series A in 2022
CHARM Therapeutics is focused on developing innovative medicines using advanced 3D deep learning and drug discovery technologies. The company's platform aims to address undruggable disease targets, providing healthcare professionals with effective treatment options for challenging medical conditions. By leveraging cutting-edge technology, CHARM Therapeutics seeks to create transformative therapies that have the potential to significantly improve patient outcomes.
Anagenex
Series A in 2022
Anagenex is a seed stage biotechnology company focused on advancing drug discovery through its innovative platform. The company aims to tackle challenging pharmaceutical targets by utilizing a technology that combines machine learning with DNA-encoded libraries. This approach allows for the rapid analysis of compounds and the generation of extensive data sets, facilitating parallel biochemical experiments. By leveraging proprietary artificial intelligence models, Anagenex enables researchers to efficiently develop new small molecule drugs for medically significant applications.
Nitricity
Venture Round in 2022
Nitricity is an energy company focused on the production of renewable nitrogen fertilizers with zero carbon emissions. It specializes in creating electrified, climate-smart fertilizers, specifically nitric acid and ammonia, which can be utilized independently or together to produce ammonium nitrate fertilizer. This innovative approach aims to bring high-quality fertilizer products closer to farmers, allowing them to minimize wasteful runoff and optimize fertilizer application timing based on field readiness. By enhancing nitrogen delivery capabilities, Nitricity supports sustainable agricultural practices and contributes to environmentally responsible farming worldwide.
Nomagic
Series A in 2022
Nomagic, Inc. is a company based in Warsaw, Poland, specializing in robotic manipulation solutions for order fulfillment in e-commerce warehouses. By providing smart pick-and-place robotic systems, Nomagic enhances efficiency, flexibility, and reliability in the logistics process. Their technology automates repetitive tasks, reduces fulfillment costs, and addresses labor shortages, allowing warehouses to operate seamlessly around the clock. The company's robots have already been implemented on packing lines at Cdiscount, a leading French e-commerce platform. Utilizing artificial intelligence, Nomagic's systems continuously learn and adapt to changing conditions, improving the agility of warehouse operations and ensuring reliable delivery of goods.
Adyton PBC
Venture Round in 2022
Adyton PBC is a company that designs and develops cloud-based software focused on reporting, data maintenance, and scheduling. Its primary offerings include AKADEMIA, a real-time reporting and analytics platform that manages training data, and Smart Schedule, which oversees training, qualifications, and daily operations. Additionally, the company provides the Adyton Operations Kit (AOK), a secure mobile software solution tailored for mission-critical work, allowing users to access data securely while on the move. Adyton PBC serves various sectors, including defense, heavy industries, law enforcement, and emergency response. Founded in 2018, the company is headquartered in Wilmington, Delaware.
VitroLabs
Series A in 2022
VitroLabs, Inc. is a startup based in San Jose, California, specializing in 3D tissue engineering and biomaterials. Founded in 2016, the company focuses on developing a scalable platform that utilizes advanced stem cell technologies to create authentic, lab-grown leather and other biomaterials. VitroLabs aims to provide a sustainable alternative to traditional animal-derived products, enabling fashion brands and interior designers to manufacture high-quality items without the ethical and environmental concerns associated with animal agriculture. By leveraging the latest advancements in stem cell research, VitroLabs is positioned at the forefront of innovation in the biomaterials industry.
Farther
Series A in 2022
Farther is a technology-driven wealth management firm founded in 2019, aimed at serving high-net-worth professionals with a holistic approach to financial management. The firm integrates expert financial advisors with advanced technology to enhance client experiences and deliver personalized advice. Farther's platform utilizes a proprietary algorithm to provide tailored investment recommendations, focusing on allocations of exchange-traded funds based on individual client data, financial situations, and risk tolerance. By combining personal service with sophisticated analytics, Farther seeks to redefine wealth management standards, ensuring that clients receive both trusted guidance and innovative financial solutions to achieve their long-term financial goals.
Primer
Series A in 2022
Primer operates an online platform that offers personalized education solutions for students. Based in San Francisco, California, the company focuses on creating microschools where learners can progress at their own pace and explore their interests. The educational environment is designed to support students in developing their skills and knowledge, preparing them for future leadership roles. Through its innovative approach, Primer aims to meet the diverse educational needs of today’s learners.
Leaft Foods
Series A in 2022
Leaft Foods focuses on reducing the environmental impact of food production through innovative plant-based protein solutions. The company specializes in extracting Rubisco, a protein derived from green leaves, which is one of the most abundant proteins available. By utilizing natural sources of protein that possess both nutritional value and functional properties, Leaft Foods enables food companies to create sustainable and healthful food products. Their production process emphasizes the use of lush green leaves, ensuring that the ingredients are both environmentally friendly and beneficial for human health.
WorldCoin
Funding Round in 2022
World is a company that connects users through a privacy-focused network designed for secure digital asset management. It offers a digital currency platform that emphasizes both privacy and transparency using a permissionless blockchain. The World App enables users to securely store their World ID, manage digital assets, and access various Mini Apps, promoting global connectivity and trust. Additionally, World provides an iris-scanning device that enhances digital identity security by storing biometric information, which helps discourage spammers from creating multiple accounts. This combination of secure identity management and digital currency aims to facilitate a reliable and user-friendly digital environment.
Cor
Series A in 2022
COR helps you implement globally-proven healthy lifestyle practices, then shows you a totally new type of data about how your body responds. Optimize your lifestyle and discover the impact of different daily customs with precise, science-based self-knowledge.
&Ava
Series A in 2022
Ava is a company that specializes in a live captioning platform utilizing artificial intelligence to transcribe spoken language into text. This application aims to enhance accessibility for the 466 million individuals worldwide who are deaf or hard of hearing. By translating conversations into color-coded text and providing instant captions, Ava facilitates seamless engagement in group discussions and other social interactions. The platform not only empowers deaf and hard-of-hearing individuals to participate more fully in their environments but also fosters improved communication and connection among all participants.
Volta Labs
Series A in 2022
Volta Labs, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2018. The company specializes in developing tools for biological automation, focusing on scalable automation solutions for genetic engineering. Volta Labs operates a platform designed for affordable genomic sample preparation, aimed at revolutionizing genomics research. This platform leverages automation and miniaturization technologies to streamline the creation of biological samples. By integrating expertise from engineering, surface chemistry, and molecular biology, Volta Labs enables biotech organizations to automate complex biological workflows, facilitating advancements in genomics and genetic engineering.
Aether Diamonds
Series A in 2022
Aether Diamonds produces the world's first and only diamonds made 100% from captured carbon. Certified B Corp. 2022 Fast Company Top 10 Most Innovative Consumer Goods Companies. 2022 "Best for the World" B Corp.
Emi Labs
Series A in 2022
Emi Labs is focused on enhancing access to professional opportunities for Frontline Workers, who represent over 70% of the global workforce but often lack visibility due to limited data on their skills and career histories. To address this challenge, Emi Labs has developed a technology-based recruitment platform that utilizes AI to streamline the hiring process. The platform automates key tasks such as candidate screening, interview scheduling, and communication, thereby saving time for recruiters and improving overall efficiency. By fostering a more engaging and human-centered recruitment experience, Emi Labs aims to connect qualified candidates with high-volume job openings. The company maintains a remote-first culture, with office hubs located in Buenos Aires, Mexico City, and San Francisco.
WorkWhile
Series A in 2022
WorkWhile is an hourly labor technology platform that connects workers with flexible job opportunities across various sectors, including warehouse, light industrial, delivery, hospitality, food production, and event services. Founded in 2017 and based in San Francisco, the platform utilizes cognitive science and behavioral analysis to effectively match workers to shifts that align with their skills, availability, and location. In addition to facilitating job placements, WorkWhile offers workers benefits such as next-day pay and sick leave credits, enhancing their overall experience. The platform also provides employers with access to a pre-screened workforce, helping them efficiently fill open positions ranging from last-minute shifts to full-time roles.
Verdagy
Series A in 2022
Verdagy is focused on advancing water electrolysis technology to enable large-scale production of green hydrogen. Based in Moss Landing, California, the company develops high-performance cells, electrolyzers, and plants aimed at achieving low upfront capital and operating costs. Their innovative approach positions them to offer competitive unit economics in hydrogen production, making it more accessible for various industries to adopt clean energy solutions. Verdagy operates laboratory and pilot plant facilities to support the rapid scaling of its technology platform.
LEX Markets
Series A in 2022
LEX Markets Corp. operates an online marketplace dedicated to commercial real estate securities, allowing users to search, buy, and sell shares of individual properties. Founded in 2018 and based in New York, the company facilitates the process of taking commercial buildings public through single-asset initial public offerings (IPOs). LEX Markets caters to both accredited and non-accredited investors, enabling transactions with a minimum investment of $250 and without lockup periods. The platform leverages technology from Nasdaq, ensuring robust trading features and performance comparable to major global markets.
Cellino
Series A in 2022
Cellino is focused on creating an automated biomanufacturing system for personalized cell therapies, with the aim of making these treatments widely accessible. The company leverages an AI-guided laser editing platform that employs image-guided machine learning and robotics to generate autologous induced pluripotent stem cells (iPSCs) at scale. This innovative approach is designed to facilitate the development of potentially curative therapies for chronic degenerative diseases, such as vision loss and Parkinson's disease. By streamlining the process of cell therapy production, Cellino aims to enhance the availability of life-saving medicines for patients around the world.
Culdesac
Series A in 2022
Culdesac Inc. is a real estate developer based in San Francisco, California, focused on creating car-free neighborhoods in the United States. Founded in 2018, the company is currently developing its first project in Tempe, Arizona, which aims to be the first car-free residential community built from scratch in the country. This innovative neighborhood will feature no parking spaces for residents, instead providing facilities for visitors, including grocery stores, coffee shops, coworking spaces, and market halls. By promoting eco-friendly living, Culdesac encourages residents to engage with their surroundings directly, enhancing their quality of life and fostering community interaction. The company has secured $17 million in venture funding from notable investors, including Khosla Ventures, Zigg Capital, and Initialized Capital.
Azibo
Series A in 2022
Azibo is a financial services platform based in Reno, Nevada, that caters to the needs of small real estate owners. Founded in 2018, Azibo offers a comprehensive digital banking solution designed to streamline property management tasks. The platform enables users to collect applications, screen tenants, generate and e-sign leases, manage rent collection, and handle accounting and financial reporting. Additionally, it simplifies maintenance management and facilitates banking and bill payments. By automating these processes, Azibo enhances operational efficiency and reduces the administrative burden associated with managing rental properties.
Fountain Therapeutics
Series A in 2021
Fountain Therapeutics, Inc. is a biotechnology company focused on developing treatments for age-related diseases. Founded in 2018 and based in San Francisco, California, the company aims to create a future where individuals live healthier for longer. It employs a transformative cellular model that mimics the complex characteristics of aging within a laboratory setting. By integrating this model with advanced artificial intelligence and computer vision, Fountain Therapeutics seeks to establish an innovative platform for identifying novel therapeutic targets. This approach is designed to facilitate the development of effective treatments for diseases associated with aging, ultimately aiming to reverse cellular aging and improve health outcomes.
Mimica Automation
Series A in 2021
Mimica Automation Limited, founded in 2018 and based in London, develops innovative software that leverages machine learning algorithms to automate repetitive tasks. By observing user interactions, such as clicks and keystrokes, for a period of two to three weeks, the software derives intent and generates automation solutions automatically. Its key offering, the mapper, gathers data from employees' computers to create a comprehensive process map by analyzing and merging the recorded activities. Backed by Entrepreneur First, a prominent accelerator and seed fund in Europe, Mimica aims to enhance workplace efficiency by simplifying the automation of routine tasks.
Splash
Series A in 2021
Splash develops AI-powered video games that lets anyone create and perform music to live audiences inside virtual venues.
Supplant
Series A in 2021
Supplant is a biotechnology platform working in the food sector. It develops natural food ingredients from agricultural resources to allow food manufacturers to decrease sugar, increase fiber, and boost the gut health-promoting qualities of its products.
Loop
Series A in 2021
Loop Health is a healthcare provider based in Pune, India, founded in 2018. The company offers a range of services including acute and urgent care, chronic condition management, women's health, health coaching, and preventive care. Loop Health aims to simplify the healthcare experience by connecting patients with family physicians, specialists, and hospitals, facilitating access to major medical treatments. Their team of Loop Coordinators assists patients in finding appropriate doctors, comparing treatment costs, obtaining second opinions, and managing admission procedures, thereby alleviating the stress associated with healthcare decisions. Additionally, Loop Health features a virtual medical practice that supports employees and their families, allowing them to consult with healthcare experts and medical advisors without delay, ultimately promoting better health management and cost-effectiveness.
VitroLabs
Series A in 2021
VitroLabs, Inc. is a startup based in San Jose, California, specializing in 3D tissue engineering and biomaterials. Founded in 2016, the company focuses on developing a scalable platform that utilizes advanced stem cell technologies to create authentic, lab-grown leather and other biomaterials. VitroLabs aims to provide a sustainable alternative to traditional animal-derived products, enabling fashion brands and interior designers to manufacture high-quality items without the ethical and environmental concerns associated with animal agriculture. By leveraging the latest advancements in stem cell research, VitroLabs is positioned at the forefront of innovation in the biomaterials industry.
Loyal
Series A in 2021
Loyal is a biotechnology company focused on developing veterinary pharmaceuticals aimed at extending the lifespan and improving the health span of dogs. By creating medications that target the aging process, Loyal seeks to delay or prevent the onset of age-related diseases, including cancer, heart disease, and metabolic disorders. The company's innovative approach involves quantifying and regulating the biological processes associated with aging, which helps to mitigate the severity of these ailments. Through its research and product development, Loyal strives to ensure that dogs can enjoy longer, healthier lives, ultimately benefiting both pets and their owners.
Vanan Online Services
Series A in 2021
Vanan Online Services is a global provider of language support services, catering to both individual and business clients. The company specializes in a wide range of services, including audio and video transcription, certified translation, closed captioning, subtitling, document typing, and legal typing. Additionally, Vanan offers audio voiceover, video animation, and video editing services.
Juno
Series A in 2021
Juno Residential, Inc. is a company based in San Francisco, California, focused on the development of residential apartments. Established in 2018, Juno Residential specializes in creating prefabricated housing solutions that prioritize environmental sustainability. The company employs innovative prefabrication techniques and utilizes organic, low-carbon materials such as mass timber to construct modern and curated living spaces. By offering these eco-friendly and efficient housing alternatives, Juno aims to address the growing demand for sustainable residential options.
PolyAI
Series A in 2021
PolyAI Ltd is a company that specializes in developing a conversational artificial intelligence platform aimed at enhancing human-machine voice interactions. Founded in 2017 and headquartered in London, United Kingdom, with an additional office in New York, the company focuses on creating enterprise voice assistants capable of engaging in natural conversations with customers. These assistants utilize advanced machine learning and natural language processing to understand and respond to customer inquiries, regardless of phrasing or dialect. The platform supports features such as multilingual capabilities, data acquisition, and dynamic flow design, facilitating the creation of human-like interactions and improving customer service experiences across various industries.
Flow Neuroscience
Series A in 2021
Flow Neuroscience, established in 2011 and based in Malmö, Sweden, specializes in developing and manufacturing a wearable device and accompanying mobile application for medication-free treatment of depression. The company's core product is a transcranial direct current stimulation (tDCS) headset that targets the left frontal lobe, an area of the brain often associated with depression. This non-invasive treatment is complemented by a personalized mobile app that encourages users to adopt healthier daily routines, such as regular exercise and sleep patterns, to help alleviate depressive symptoms. Flow Neuroscience aims to make this innovative, affordable treatment accessible to the public, challenging the dominance of pharmaceuticals in mental health care.
Connie Health
Series A in 2021
Connie Health is a company focused on enhancing the healthcare decision-making process for older Americans, particularly those navigating Medicare. It provides medical advisory services designed to improve the customer experience in selecting and managing healthcare plans. Utilizing an AI-driven technology platform alongside local Medicare experts, Connie Health assists individuals in maximizing their insurance benefits, optimizing prescription costs, and locating healthcare providers in their vicinity. This comprehensive approach empowers seniors to make informed choices about their healthcare plans and effectively navigate their plan's benefits.
IgGenix
Series A in 2021
IgGenix, Inc. is a biotechnology company focused on developing innovative antibody therapeutics for the treatment of food and other severe allergies. Founded in 2019 and based in South San Francisco, California, the company specializes in isolating and transforming allergen-specific IgE antibodies into IgG antibodies. This process aims to alleviate and prevent allergic reactions by suppressing the allergic cascade. IgGenix captures and analyzes rare human B cells that produce allergen-binding antibodies and engineers these cells to enhance their immune-modulating properties. By addressing critical needs in the medical industry, IgGenix seeks to provide effective solutions for life-threatening allergic reactions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.